Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CURE vs. ELIL: which is better?

Bottom line

CURE vs ELIL: the short answer

CURE (Direxion Daily Healthcare Bull 3X ETF) and ELIL (Direxion Daily LLY Bull 2X ETF) are both etfs.

But CURE is far broader, holding 67 positions to 9 for ELIL, so beyond the top names it adds exposure ELIL doesn't have.

CURE is cheaper at 0.94% vs 1.07% — a difference of $13 a year per $10,000 invested.

Updated Nov 19, 2026

CURE vs ELIL side by side

CUREELIL
TypeETFETF
Fund familyDirexionDirexion
CategoryLeveraged & InverseLeveraged & Inverse
Expense ratio0.94%1.07%
Annual cost per $10k$94$107
10-yr cost on $10k (prospectus)$1,155$1,558
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+22.9%—
5-yr return (annualized)+8.6%—
10-yr return (annualized)+13.6%—
Best quarter+46.9%—
Worst quarter−45.8%—
Net assets (fund)$171.7M$18.3M
Number of holdings679
Portfolio turnover1%%
Returns as ofDec 31, 2025—

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

7 of CURE's top 25 holdings also appear in ELIL's top 9.

Shared top holdings
HoldingCUREELIL
Dreyfus18.79%15.35%
Eli Lilly & Company10.41%15.09%
N/a8.28%-4.85%
Goldman Sachs Liq Es Fd A8.19%32.52%
Goldman Financial7.51%14.01%
N/a3.34%-4.85%
N/a1.12%-4.85%

Source: SEC Form N-PORT

CURE top 10

  1. Dreyfus — 18.79%
  2. Eli Lilly & Company — 10.41%
  3. N/a — 8.28%
  4. Goldman Sachs Liq Es Fd A — 8.19%
  5. Goldman Financial — 7.51%
  6. Johnson & Johnson — 7.07%
  7. Abbvie Inc — 5.08%
  8. Unitedhealth Group Inc — 4.31%
  9. Merck & Company Inc — 3.68%
  10. N/a — 3.34%

ELIL top 10

  1. Goldman Sachs Liq Es Fd A — 32.52%
  2. Dreyfus — 25.97%
  3. Dreyfus — 15.35%
  4. Eli Lilly & Company — 15.09%
  5. Goldman Financial — 14.01%
  6. N/a — 0.82%
  7. N/a — 0.17%
  8. N/a — -2.96%
  9. N/a — -4.85%

FAQ

What is the difference between CURE and ELIL?
CURE (Direxion Daily Healthcare Bull 3X ETF) and ELIL (Direxion Daily LLY Bull 2X ETF) are both etfs. But CURE is far broader, holding 67 positions to 9 for ELIL, so beyond the top names it adds exposure ELIL doesn't have.
Which is cheaper, CURE or ELIL?
CURE has the lower expense ratio (0.94%).
Should I own both CURE and ELIL?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.